Citigroup Inc Third Harmonic Bio, Inc. Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 16,509 shares of THRD stock, worth $170,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,509
Previous 5,464
202.14%
Holding current value
$170,372
Previous $71,000
214.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$113 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$59.6 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$45.1 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$32.8 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$30.5 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $416M